Pharmafile Logo
Pharmafocus logo
Advanced Search

AZ’s Imfinzi hits second major milestone at Phase 3 in unresectable lung cancer

May 25, 2018
Medical Communications, Research and Development AstraZeneca, Imfinzi, NSCLC, lung cancer, pharma

AstraZeneca and its global biologics R&D MedImmune have lifted the curtain on new Phase 3 data for their immunotherapy Imfinzi …

News
breast_cancer_scan

Breast cancer screening scandal potentially involves even more women

May 25, 2018
Medical Communications Jeremy Hunt, NHS, biotech, drugs, pharma, pharmaceutical

The news broke at the start of the month that a number of women who should have been invited to …

News
prothena-37882-2

Prothena guts workforce by more than half, after trial failure

May 25, 2018
Medical Communications Neil Woodford, Prothena, Roche, biotech, drugs, pharma, pharmaceutical

Prothena Therapeutics has acted drastically by slashing staff numbers by more than half, after the failure of two pivotal trials …

News
teething__daniel_schwen

FDA cracks down on benzocaine teething products

May 24, 2018
Sales and Marketing FDA, benzocaine, pharma, teething products

The FDA has put its foot down on over-the-counter teething products for infants and children which contain benzocaine, a pain …

News
john_crowley_edit

John Crowley speaks on drug development and the FDA

May 24, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amicus Therapeutics, John Crowley, biotech, drugs, pharma, pharmaceutical

Pharmafocus spoke to John Crowley, CEO of Amicus Therapeutics, about his highly unusual career in the pharmaceutical and biotech industries.

Feature
astellas_tokyo_copy

Astellas begins major restructure, as 600 jobs slashed

May 24, 2018
Medical Communications Astellas, biotech, drugs, pharma, pharmaceutical

Astellas, under the direction of new CEO, Kenji Yasukawa, has unveiled a major new restructure, ahead of a difficult looking …

News
novartis_outside_1

Novartis’ Sandoz scores EU approval for Remicade biosimilar

May 24, 2018
Sales and Marketing EU, Europe, Novartis, Remicade, Sandoz, Zessly, pharma

The European Commission has given its approval to Sandoz, Novartis’ generics and biosimilars unit, for its biosimilar version of Janssen’s …

News
nhs_parliament_2_4

Report calls for tax rises to fund ailing NHS

May 24, 2018
Medical Communications IFS, NHS, UK government, biotech, drugs, pharma, pharmaceutical

A report published by the Institute for Fiscal Studies (IFS) has stressed that UK funding into the NHS needs to …

News
merck_and_co

MSD’s Keytruda scores impressive first-line lung cancer data

May 24, 2018
Research and Development, Sales and Marketing MSD, biotech, drugs, keytruda, pharma, pharmaceutical

MSD Keytruda has enjoyed the most success of the PD-1/L1 therapies in clinical trials recently and it’s rapidly cementing its …

News
handshake_2

Vifor Fresenius snap up rights to Cara’s itch therapy

May 23, 2018
Research and Development, Sales and Marketing Cara Therapeutics, Vifor Fresenius, biotech, drugs, pharma, pharmaceutical

The joint partnership between Vifor Pharma and Fresenius Medical Care, Vifor Fresenius, has put down $50 in upfront cash and …

News
fda2outsideweb

Sun Pharma drug combo scores FDA approval in advanced castration-resistant prostate cancer

May 23, 2018
Research and Development, Sales and Marketing Cancer, Churchill Pharmaceuticals, FDA, Sun Pharma, US, Yonsa, pharma, prostate cancer

Sun Pharma is celebrating with the announcement that its CYP17 inhibitor Yonsa (abiraterone acetate) has been awarded FDA approval in …

News
obese-3011213_960_720

World heading towards 25% of total population being obese

May 23, 2018
Research and Development WHO, biotech, drugs, obesity, pharma, pharmaceutical

The latest global research paints a bleak picture of future global public health, predicting that almost a quarter of the …

News
512px-kratom_leaves_3

FDA reprimands suppliers of opioid substitute kratom products

May 23, 2018
Research and Development, Sales and Marketing FDA, kratom, opioid crisis, opioids, pharma

The ongoing opioid epidemic in the US has seen the rise of the sale and use of kratom (mitragyna speciose), …

News
takeda_tokyo_hq

Takeda begins to shore up finances with $280m divestment

May 23, 2018
Research and Development, Sales and Marketing Takeda, biotech, drugs, pharma, pharmaceutical

Much has already been written about Takeda and its massive financial stretch to pull in the Shire acquisition, in the …

News
640px-hiv-budding-color

India, Sweden and The Netherlands form HIV/AIDS research partnership

May 22, 2018
Manufacturing and Production, Research and Development AIDS, HIV, India, Sweden, The Netherlands, pharma

A first-of-its-kind collaboration has been announced by the governments of India, Sweden and The Netherlands with the goal of advancing …

News

NHS Trust harnesses AI to speed up treatment

May 22, 2018
Manufacturing and Production, Medical Communications AI, NHS, biotech, drugs, pharma, pharmaceutical

The Royal Liverpool and Broadgreen University Hospitals NHS Trust has teamed up with a provider of AI systems to introduce …

News
brothers-457237_960_720

The cause of the most common form of childhood cancer found

May 22, 2018
Manufacturing and Production, Research and Development biotech, drugs, leukaemia, pharma, pharmaceutical

Professor Mel Greaves, of The Institute of Cancer Research, has spent 30 years uncovering what is behind the mysterious rise …

News
landing-hero-images1

ViiV’s two-drug regimen gets EU approval for HIV-1

May 22, 2018
Manufacturing and Production, Sales and Marketing EMA, EU, Europe, HIV, Juluca, ViiV Healthcare, pharma

ViiV Healthcare has announced that its HIV therapy Juluca (dolutegravir/rilpivirine) has been awarded marketing authorisation in the EU from the …

News
pills_shot

Nabriva closes in on bringing new class of antibiotic to market

May 22, 2018
Manufacturing and Production, Sales and Marketing Antibiotics, Nabriva Therapeutics, biotech, drugs, pharma, pharmaceutical

Nabriva Therapeutics, a biotech based in Dublin, Ireland, has announced positive Phase 3 data for its antibiotic, lefamulin, which could …

News
gilead-sciences

Gilead expands operations in Cork, Ireland

May 21, 2018
Manufacturing and Production, Sales and Marketing Gilead, Ireland, biotech, drugs, pharma, pharmaceutical

Gilead has unveiled the expansion of its Cork manufacturing site, involved in the creation of its treatments for HIV and …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026